NM_001101362.3:c.-17C>T

Variant summary

Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The NM_001101362.3(KBTBD13):​c.-17C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000205 in 1,505,674 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.00028 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00020 ( 3 hom. )

Consequence

KBTBD13
NM_001101362.3 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.98
Variant links:
Genes affected
KBTBD13 (HGNC:37227): (kelch repeat and BTB domain containing 13) The gene belongs to a family of genes encoding proteins containing a BTB domain and several kelch repeats. The BTB domain functions as a protein-protein interaction module, which includes an ability to self-associate or to interact with non-BTB domain-containing proteins. The kelch motif typically occurs in groups of five to seven repeats, and has been found in proteins with diverse functions. Known functions of these family members include transcription regulation, ion channel tetramerization and gating, protein ubiquitination or degradation, and cytoskeleton regulation. The exact function of this family member has yet to be determined. [provided by RefSeq, Jun 2010]
RASL12 (HGNC:30289): (RAS like family 12) Predicted to enable GDP binding activity; GTP binding activity; and GTPase activity. Predicted to be involved in signal transduction. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 15-65076799-C-T is Benign according to our data. Variant chr15-65076799-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 389836.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 42 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KBTBD13NM_001101362.3 linkc.-17C>T 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 1 ENST00000432196.5 NP_001094832.1 C9JR72
KBTBD13NM_001101362.3 linkc.-17C>T 5_prime_UTR_variant Exon 1 of 1 ENST00000432196.5 NP_001094832.1 C9JR72
RASL12NM_001379429.1 linkc.-201G>A upstream_gene_variant NP_001366358.1
RASL12XM_011521660.4 linkc.-250G>A upstream_gene_variant XP_011519962.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KBTBD13ENST00000432196 linkc.-17C>T 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 1 NM_001101362.3 ENSP00000388723.2 C9JR72
KBTBD13ENST00000432196 linkc.-17C>T 5_prime_UTR_variant Exon 1 of 1 NM_001101362.3 ENSP00000388723.2 C9JR72
RASL12ENST00000434605.2 linkc.-201G>A upstream_gene_variant 2 ENSP00000412787.2 Q9NYN1-2

Frequencies

GnomAD3 genomes
AF:
0.000282
AC:
43
AN:
152240
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00597
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.000956
GnomAD3 exomes
AF:
0.000577
AC:
71
AN:
123118
Hom.:
1
AF XY:
0.000595
AC XY:
40
AN XY:
67204
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000223
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00528
Gnomad SAS exome
AF:
0.000263
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00108
GnomAD4 exome
AF:
0.000197
AC:
267
AN:
1353316
Hom.:
3
Cov.:
28
AF XY:
0.000187
AC XY:
124
AN XY:
663118
show subpopulations
Gnomad4 AFR exome
AF:
0.0000324
Gnomad4 AMR exome
AF:
0.000209
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00423
Gnomad4 SAS exome
AF:
0.000318
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000302
Gnomad4 OTH exome
AF:
0.000942
GnomAD4 genome
AF:
0.000276
AC:
42
AN:
152358
Hom.:
0
Cov.:
33
AF XY:
0.000376
AC XY:
28
AN XY:
74514
show subpopulations
Gnomad4 AFR
AF:
0.0000240
Gnomad4 AMR
AF:
0.000261
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00579
Gnomad4 SAS
AF:
0.000414
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.000946
Alfa
AF:
0.000106
Hom.:
0
Bravo
AF:
0.000370
Asia WGS
AF:
0.0110
AC:
37
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Jul 28, 2017
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
3.4
DANN
Benign
0.67

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs372844012; hg19: chr15-65369137; API